Business
Ventripoint Receives European Union Medical Device Regulation Certification
(TheNewswire) Toronto, O N - TheNewswire - May 30, 2023 - Ventripoint Diagnosti...
About this update from Ventripoint Diagnostics Ltd.
[{"type":"text","content":"Ventripoint Receives European Union Medical Device Regulation Certification\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Toronto, O\n \n \n N\n \n \n -\nTheNewswire - May 30, 2023 -\n \n \n Ventripoint\nDiagnostics Ltd. (\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"),\n \n \n (TSXV:VPT\n \n \n )\n \n \n (\n \n \n OTC:VPTDF)\n \n \n is pleased to announce that it has successfully obtained\nEuropean Union Medical Device Regulation (EU MDR) certification for\nits cardiac diagnostic system. This significant milestone further\nunderscores Ventripoint’s dedication to delivering state-of-the-art\ndiagnostic tools to healthcare professionals and improving patient\noutcomes.\n \n \n \n \n The EU MDR certification came into effect in May 2021.\nAll medical devices certified under the previous Medical Device\nDirective (MDD) in the EU must certify to the new requirements\n(\n \n \n MDR 2017/745)\n \n \n to be sold\nin the European Market.\n \n \n \n \n By receiving its EU MDR certification, Ventripoint\nDiagnostics demonstrates its ability to meet the evolving regulatory\nlandscape and provide a safe and effective cardiac diagnostic tool for\nhospitals and cardiac clinics. Ventripoint Diagnostics is poised to\nexpand its presence in the European market and further its mission to\ntransform the way cardiac diseases are diagnosed and managed.\n \n \n \n \n About Ventripoint Diagnostics\nLtd.\n \n \n \n \n Ventripoint\n \n \n has become an\nindustry leader in the application of AI (Artificial Intelligence) to\nechocardiography. Ventripoint's VMS products are powered by its\nproprietary KBR technology, which is the result of a decade of\ndevelopment and provides accurate volumetric cardiac measurements\nequivalent to MRI. This affordable, gold-standard alternative allows\ncardiologists greater confidence in the management of their patients.\nProviding better care to patients serves as a springboard and basic\nstandard for all of Ventripoint's products that guide our future\ndevelopments. In addition, VMS+ is versatile and can be used with all\nultrasound systems from any vendor supported by regulatory market\napprovals in the U.S., Europe and Canada.\n \n \n \n \n For\n \n \n further information, please\ncontact:\n \n \n \n \n Jonathan Robinson\n \n \n \n \n Email:\n \n ...